Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Priti Gupta is active.

Publication


Featured researches published by Priti Gupta.


Journal of Clinical Microbiology | 2007

Comparative Evaluation of Lowenstein-Jensen Proportion Method, BacT/ALERT 3D System, and Enzymatic Pyrazinamidase Assay for Pyrazinamide Susceptibility Testing of Mycobacterium tuberculosis

Pushpendra Singh; Clement Wesley; G. P. S. Jadaun; Sunil Kumar Malonia; R. Das; Prashant Upadhyay; Jaya Faujdar; P Sharma; Priti Gupta; Abhay Kumar Mishra; Kalpana Singh; D. S. Chauhan; V. D. Sharma; Unnati Gupta; K. Venkatesan; Katoch Vm

ABSTRACT Pyrazinamide (PZA) is an important first-line antituberculosis drug because of its sterilizing activity against semidormant tubercle bacilli. In spite of its very high in vivo activity, its in vitro activity is not apparent unless an acidic environment is available, which makes PZA susceptibility testing difficult by conventional methods. The present study was, therefore, planned to assess the performance of the colorimetric BacT/ALERT 3D system and compare the results with those from conventional tests, i.e., the Löwenstein-Jensen (LJ) proportion method (pH 4.85) and Waynes pyrazinamidase (PZase) assay, using 107 clinical isolates. The concordance among all of these tests was 89.71% after the first round of testing and reached 92.52% after resolution of the discordant results by retesting. Prolonged incubation of the PZase tube for up to 10 days was found to increase the specificity of the PZase test. The concordances between LJ proportion and BacT/ALERT 3D, LJ proportion and the PZase assay, and BacT/ALERT 3D and the PZase assay were found to be 99.06%, 93.46%, and 92.52%, respectively. Using the LJ results as the gold standard, the sensitivities of BacT/ALERT 3D and the PZase assay were 100 and 82.85%, respectively, while the specificity was 98.61% for both of the tests. The difference between the sensitivities of BacT/ALERT 3D and the PZase assay was significant (P = 0.025). The mean turnaround times for the detection of resistant and susceptible results by BacT/ALERT 3D were 8.04 and 11.32 days, respectively. While the major limitations associated with the PZase assay and the LJ proportion method are lower sensitivity in previously treated patients and a longer time requirement, respectively, the BacT/ALERT 3D system was found to be rapid, highly sensitive, and specific.


Nutrients | 2017

The Association of Knowledge and Behaviours Related to Salt with 24-h Urinary Salt Excretion in a Population from North and South India.

Claire Johnson; Sailesh Mohan; Kris Rogers; Roopa Shivashankar; Sudhir Raj Thout; Priti Gupta; Feng J. He; Graham A. MacGregor; Jacqui Webster; Anand Krishnan; Pallab K. Maulik; Kolli Srinath Reddy; Dorairaj Prabhakaran; Bruce Neal

Consumer knowledge is understood to play a role in managing risk factors associated with cardiovascular disease and may be influenced by level of education. The association between population knowledge, behaviours and actual salt consumption was explored overall, and for more-educated compared to less-educated individuals. A cross-sectional survey was done in an age-and sex-stratified random sample of 1395 participants from urban and rural areas of North and South India. A single 24-h urine sample, participants’ physical measurements and questionnaire data were collected. The mean age of participants was 40 years, 47% were women and mean 24-h urinary salt excretion was 9.27 (8.87–9.69) g/day. Many participants reported favourable knowledge and behaviours to minimise risks related to salt. Several of these behaviours were associated with reduced salt intake—less use of salt while cooking, avoidance of snacks, namkeens, and avoidance of pickles (all p < 0.003). Mean salt intake was comparable in more-educated (9.21, 8.55–9.87 g/day) versus less-educated (9.34, 8.57–10.12 g/day) individuals (p = 0.82). There was no substantively different pattern of knowledge and behaviours between more-versus less-educated groups and no clear evidence that level of education influenced salt intake. Several consumer behaviours related to use of salt during food preparation and consumption of salty products were related to actual salt consumption and therefore appear to offer an opportunity for intervention. These would be a reasonable focus for a government-led education campaign targeting salt.


Journal of the American Heart Association | 2017

Mean Dietary Salt Intake in Urban and Rural Areas in India: A Population Survey of 1395 Persons

Claire Johnson; Sailesh Mohan; Kris Rogers; Roopa Shivashankar; Sudhir Raj Thout; Priti Gupta; Feng J. He; Graham A. MacGregor; Jacqui Webster; Anand Krishnan; Pallab K. Maulik; Kolli Srinath Reddy; Dorairaj Prabhakaran; Bruce Neal

Background The scientific evidence base in support of population‐wide salt reduction is strong, but current high‐quality data about salt intake levels in India are mostly absent. This project sought to estimate daily salt consumption levels in selected communities of Delhi and Haryana in north India and Andhra Pradesh in south India. Methods and Results In this study, 24‐hour urine samples were collected using an age‐ and sex‐stratified sampling strategy in rural, urban, and slum areas. Salt intake estimates were made for the overall population of each region and for major subgroups by weighting the survey data for the populations of Delhi and Haryana, and Andhra Pradesh. Complete 24‐hour urine samples were available for 637 participants from Delhi and Haryana and 758 from Andhra Pradesh (65% and 68% response rates, respectively). Weighted mean population 24‐hour urine excretion of salt was 8.59 g/day (95% CI 7.68–9.51) in Delhi and Haryana and 9.46 g/day (95% CI 9.06–9.85) in Andhra Pradesh (P=0.097). Estimates inflated to account for the minimum likely nonurinary losses of sodium provided corresponding estimates of daily salt intake of 9.45 g/day (95% CI 8.45–10.46) and 10.41 g/day (95% CI 9.97–10.84), respectively. Conclusions Salt consumption in India is high, with mean population intake well above the World Health Organization recommended maximum of 5 g/day. A national salt reduction program would likely avert much premature death and disability.


PLOS ONE | 2017

Prevalence of chronic kidney disease and risk factors for its progression: A cross-sectional comparison of Indians living in Indian versus U.S. cities

Shuchi Anand; Dimple Kondal; Maria E. Montez-Rath; Yuanchao Zheng; Roopa Shivashankar; Kalpana Singh; Priti Gupta; Ruby Gupta; Vamadevan S. Ajay; Viswanathan Mohan; Rajendra Pradeepa; Nikhil Tandon; Mohammed K. Ali; K.M. Venkat Narayan; Glenn M. Chertow; Namratha R. Kandula; Dorairaj Prabhakaran; Alka M. Kanaya

Background While data from the latter part of the twentieth century consistently showed that immigrants to high-income countries faced higher cardio-metabolic risk than their counterparts in low- and middle-income countries, urbanization and associated lifestyle changes may be changing these patterns, even for conditions considered to be advanced manifestations of cardio-metabolic disease (e.g., chronic kidney disease [CKD]). Methods and findings Using cross-sectional data from the Center for cArdiometabolic Risk Reduction in South Asia (CARRS, n = 5294) and Mediators of Atherosclerosis in South Asians Living in America (MASALA, n = 748) studies, we investigated whether prevalence of CKD is similar among Indians living in Indian and U.S. cities. We compared crude, age-, waist-to-height ratio-, and diabetes- adjusted CKD prevalence difference. Among participants identified to have CKD, we compared management of risk factors for its progression. Overall age-adjusted prevalence of CKD was similar in MASALA (14.0% [95% CI 11.8–16.3]) compared with CARRS (10.8% [95% CI 10.0–11.6]). Among men the prevalence difference was low (prevalence difference 1.8 [95% CI -1.6,5.3]) and remained low after adjustment for age, waist-to-height ratio, and diabetes status (-0.4 [-3.2,2.5]). Adjusted prevalence difference was higher among women (prevalence difference 8.9 [4.8,12.9]), but driven entirely by a higher prevalence of albuminuria among women in MASALA. Severity of CKD—-i.e., degree of albuminuria and proportion of participants with reduced glomerular filtration fraction-—was higher in CARRS for both men and women. Fewer participants with CKD in CARRS were effectively treated. 4% of CARRS versus 51% of MASALA participants with CKD had A1c < 7%; and 7% of CARRS versus 59% of MASALA participants blood pressure < 140/90 mmHg. Our analysis applies only to urban populations. Demographic—-particularly educational attainment—-differences among participants in the two studies are a potential source of bias. Conclusions Prevalence of CKD among Indians living in Indian and U.S. cities is similar. Persons with CKD living in Indian cities face higher likelihood of experiencing end-stage renal disease since they have more severe kidney disease and little evidence of risk factor management.


international conference on multimedia and expo | 2008

Efficient search algorithms for block-matching motion estimation

Shashi Kant; Priti Gupta; Ramkishor Korada; Mithun Uliyar

In this paper, two new and efficient algorithms for block motion estimation are presented. The proposed algorithms concentrate on improvements to existing block motion estimation algorithms (BMAs) and include four effective steps: prediction of static blocks, prediction of optimal search starting point, motion categorization for the block and motion vector search around the optimal starting point. Two different search patterns are presented that achieve different tradeoffs between search speed and reconstructed picture quality. Extensive simulation results and comparative analysis with the well-known Diamond search show that the proposed algorithms outperform conventional algorithms in terms of computational complexity while maintaining picture quality.


BMJ Open | 2017

Protocol for the mWellcare trial: a multicentre, cluster randomised, 12-month, controlled trial to compare the effectiveness of mWellcare, an mHealth system for an integrated management of patients with hypertension and diabetes, versus enhanced usual care in India

Dilip Jha; Priti Gupta; Vamadevan S. Ajay; Devraj Jindal; Pablo Perel; David Prieto-Merino; Pramod Jacob; Jonathan Nyong; Vidya Venugopal; Kavita Singh; Shifalika Goenka; Ambuj Roy; Nikhil Tandon; Vikram Patel; Dorairaj Prabhakaran

Introduction Rising burden of cardiovascular disease (CVD) and diabetes is a major challenge to the health system in India. Innovative approaches such as mobile phone technology (mHealth) for electronic decision support in delivering evidence-based and integrated care for hypertension, diabetes and comorbid depression have potential to transform the primary healthcare system. Methods and analysis mWellcare trial is a multicentre, cluster randomised controlled trial evaluating the clinical and cost-effectiveness of a mHealth system and nurse managed care for people with hypertension and diabetes in rural India. mWellcare system is an Android-based mobile application designed to generate algorithm-based clinical management prompts for treating hypertension and diabetes and also capable of storing health records, sending alerts and reminders for follow-up and adherence to medication. We recruited a total of 3702 participants from 40 Community Health Centres (CHCs), with ≥90 at each of the CHCs in the intervention and control (enhanced care) arms. The primary outcome is the difference in mean change (from baseline to 1 year) in systolic blood pressure and glycated haemoglobin (HbA1c) between the two treatment arms. The secondary outcomes are difference in mean change from baseline to 1 year in fasting plasma glucose, total cholesterol, predicted 10-year risk of CVD, depression, smoking behaviour, body mass index and alcohol use between the two treatment arms and cost-effectiveness. Ethics and dissemination The study has been approved by the institutional Ethics Committees at Public Health Foundation of India and the London School of Hygiene and Tropical Medicine. Findings will be disseminated widely through peer-reviewed publications, conference presentations and other mechanisms. Trial registration mWellcare trial is registered with Clinicaltrial.gov (Registration number NCT02480062; Pre-results) and Clinical Trial Registry of India (Registration number CTRI/2016/02/006641). The current version of the protocol is Version 2 dated 19 October 2015 and the study sponsor is Public Health Foundation of India, Gurgaon, India (www.phfi.org).


Journal of Hypertension | 2017

Estimating population salt intake in India using spot urine samples.

Kristina S. Petersen; Claire Johnson; Sailesh Mohan; Kris Rogers; Roopa Shivashankar; Sudhir Raj Thout; Priti Gupta; Feng J. He; Graham A. MacGregor; Jacqui Webster; Joseph Alvin Santos; Anand Krishnan; Pallab K. Maulik; K. Srinath Reddy; Ruby Gupta; Dorairaj Prabhakaran; Bruce Neal

Objective: To compare estimates of mean population salt intake in North and South India derived from spot urine samples versus 24-h urine collections. Methods: In a cross-sectional survey, participants were sampled from slum, urban and rural communities in North and in South India. Participants provided 24-h urine collections, and random morning spot urine samples. Salt intake was estimated from the spot urine samples using a series of established estimating equations. Salt intake data from the 24-h urine collections and spot urine equations were weighted to provide estimates of salt intake for Delhi and Haryana, and Andhra Pradesh. Results: A total of 957 individuals provided a complete 24-h urine collection and a spot urine sample. Weighted mean salt intake based on the 24-h urine collection, was 8.59 (95% confidence interval 7.73–9.45) and 9.46 g/day (8.95–9.96) in Delhi and Haryana, and Andhra Pradesh, respectively. Corresponding estimates based on the Tanaka equation [9.04 (8.63–9.45) and 9.79 g/day (9.62–9.96) for Delhi and Haryana, and Andhra Pradesh, respectively], the Mage equation [8.80 (7.67–9.94) and 10.19 g/day (95% CI 9.59–10.79)], the INTERSALT equation [7.99 (7.61–8.37) and 8.64 g/day (8.04–9.23)] and the INTERSALT equation with potassium [8.13 (7.74–8.52) and 8.81 g/day (8.16–9.46)] were all within 1 g/day of the estimate based upon 24-h collections. For the Toft equation, estimates were 1–2 g/day higher [9.94 (9.24–10.64) and 10.69 g/day (9.44–11.93)] and for the Kawasaki equation they were 3–4 g/day higher [12.14 (11.30–12.97) and 13.64 g/day (13.15–14.12)]. Conclusion: In urban and rural areas in North and South India, most spot urine-based equations provided reasonable estimates of mean population salt intake. Equations that did not provide good estimates may have failed because specimen collection was not aligned with the original method.


PLOS ONE | 2018

Stakeholders’ perceptions regarding a salt reduction strategy for India: Findings from qualitative research

Priti Gupta; Sailesh Mohan; Claire Johnson; Vandana Garg; Sudhir Raj Thout; Roopa Shivashankar; Anand Krishnan; Bruce Neal; Dorairaj Prabhakaran

Background Scientific evidence indicates that high dietary salt intake has detrimental effects on blood pressure and associated cardiovascular disease (CVD). However, limited information is available on how to implement salt reduction in low and middle-income countries (LMICs) such as India, where the burden of hypertension and CVD is increasing rapidly. As part of a large study to create the evidence base required to develop a salt reduction strategy for India, we assessed the perspectives of various stakeholders regarding developing an India specific salt reduction strategy. Methods A qualitative research design was deployed to elicit various stakeholder’s (government and policy-related stakeholders, industry, civil Society, consumers) perspectives on a salt reduction strategy for India, using in-depth interviews (IDIs) and focus group discussions (FGDs). We used an inductive approach for data analysis. Data were analyzed using thematic content analysis method. Results Forty-two IDIs and eight FGDs were conducted with various stakeholders of interest and relevance. Analysis indicated three major themes: 1. Barriers for salt reduction 2. Facilitators for salt reduction; 3. Strategies for salt reduction. Most of the stakeholders were in alignment with the need for a salt reduction programme in India to prevent and control hypertension and related CVD. Major barriers indicated by the stakeholders for salt reduction in India were social and cultural beliefs, a large unorganized food retail sector, and the lack of proper implementation of even existing food policies. Stakeholders from the food industry reported that there might be decreased sales due to salt reduction. Major facilitators included the fact that: salt reduction is currently a part of the National Multi-Sectoral Action Plan for the prevention and control of NCDs, salt reduction and salt iodine programme are compatible, and that few of the multinational food companies have already started working in the direction of initiating efforts for salt reduction. Based on the barriers and facilitators, few of the recommendations are to generate awareness among consumers, promote salt reduction by processed food industry, and implement consumer friendly food labelling. Conclusions In this study of multiple key influential stakeholders in India, most of the stakeholders were in alignment with the need for a salt reduction programme in India to prevent and control hypertension and related CVD. The development and adoption of the National Multi-sectoral Action Plan to reduce premature non-communicable diseases (NCDs) in India, provides a potential platform that can be leveraged to drive, implement and monitor salt reduction efforts.


BMJ Open | 2017

Causes of and contributors to infant mortality in a rural community of North India: evidence from verbal and social autopsy

Sanjay K. Rai; Shashi Kant; Rahul Srivastava; Priti Gupta; Puneet Misra; Chandrakant S Pandav; Arvind Kumar Singh

Objective To identify the medical causes of death and contribution of non-biological factors towards infant mortality by a retrospective analysis of routinely collected data using verbal and social autopsy tools. Setting The study site was Health and Demographic Surveillance System (HDSS), Ballabgarh, North India Participants All infant deaths during the years 2008–2012 were included for verbal autopsy and infant deaths from July 2012 to December 2012 were included for social autopsy. Outcome measures Cause of death ascertained by a validated verbal autopsy tool and level of delay based on a three-delay model using the INDEPTH social autopsy tool were the main outcome measures. The level of delay was defined as follows: level 1, delay in identification of danger signs and decision making to seek care; level 2, delay in reaching a health facility from home; level 3, delay in getting healthcare at the health facility. Results The infant mortality rate during the study period was 46.5/1000 live births. Neonatal deaths contributed to 54.3% of infant deaths and 39% occurred on the first day of life. Birth asphyxia (31.5%) followed by low birth weight (LBW)/prematurity (26.5%) were the most common causes of neonatal death, while infection (57.8%) was the most common cause of post-neonatal death. Care-seeking was delayed among 50% of neonatal deaths and 41.2% of post-neonatal deaths. Delay at level 1 was most common and occurred in 32.4% of neonatal deaths and 29.4% of post-neonatal deaths. Deaths due to LBW/prematurity were mostly followed by delay at level 1. Conclusion A high proportion of preventable infant mortality still exists in an area which is under continuous health and demographic surveillance. There is a need to enhance home-based preventive care to enable the mother to identify and respond to danger signs. Verbal autopsy and social autopsy could be routinely done to guide policy interventions aimed at reduction of infant mortality.


MedInfo | 2017

The Development of mWellcare, an mHealth System for the Integrated Management of Hypertension and Diabetes in Primary Care.

Devraj Jindal; Priti Gupta; Dilip Jha; Vamadevan S. Ajay; Pramod Jacob; Kriti Mehrotra; Pablo Perel; Jonathan Nyong; Ambuj Roy; Nikhil Tandon; Dorairaj Prabhakaran; Vikram Patel

Collaboration


Dive into the Priti Gupta's collaboration.

Top Co-Authors

Avatar

Dorairaj Prabhakaran

Public Health Foundation of India

View shared research outputs
Top Co-Authors

Avatar

Roopa Shivashankar

Public Health Foundation of India

View shared research outputs
Top Co-Authors

Avatar

Bruce Neal

The George Institute for Global Health

View shared research outputs
Top Co-Authors

Avatar

Claire Johnson

The George Institute for Global Health

View shared research outputs
Top Co-Authors

Avatar

Sudhir Raj Thout

The George Institute for Global Health

View shared research outputs
Top Co-Authors

Avatar

Ambuj Roy

All India Institute of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Anand Krishnan

All India Institute of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Devraj Jindal

Public Health Foundation of India

View shared research outputs
Top Co-Authors

Avatar

Dilip Jha

Public Health Foundation of India

View shared research outputs
Top Co-Authors

Avatar

Nikhil Tandon

All India Institute of Medical Sciences

View shared research outputs
Researchain Logo
Decentralizing Knowledge